Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial
- PMID: 32479544
- PMCID: PMC7263605
- DOI: 10.1371/journal.pone.0233876
Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial
Abstract
Many women with Polycystic Ovary Syndrome (PCOS) report high depression rates. The relationship between PCOS and these high depression rates is unclear. Two-component lifestyle interventions have revealed short-term effects on depression scores in this group of women. In general, 3-component interventions including diet, exercise, and cognitive behavioral therapy (CBT) are more effective in the long-term to improve emotional well-being. This has not yet been studied in women with PCOS. This study examined the effect of 20 CBT lifestyle (LS) sessions combined with a healthy diet and physical therapy with or without 9 months additional feedback through Short Message Service (SMS) via mobile phone, compared to care as usual (CAU, involving advice to lose weight). In this secondary analysis, 155 women with PCOS and a BMI above 25 kg/m2 were eligible. Depression scores decreased significantly in the LS programme compared to CAU (P = 0.045). In both the LS programme without SMS (P = 0.036) and the LS programme with SMS (P = 0.011) depression scores decreased while no change was observed in CAU (P = 0.875). Self-esteem scores improved significantly in the LS programme compared to CAU (P = 0.027). No differences in body image scores were observed in LS participants compared to CAU (P = 0.087), although body image improved significantly in both the LS without SMS (P = 0.001) and with SMS (P = 0.008) study arms. We found no significant mediating role by androgens in the relationship between LS participants and emotional well-being. Only weight-loss mediated the relationship between LS and self-esteem. To conclude, a three-component lifestyle intervention programme with or without additional SMS resulted in significant improvements in depression and self-esteem compared to CAU, in women with PCOS, obesity, and a wish to achieve a pregnancy. Testosterone, androstenedione, DHEA, insulin, HOMA-IR, and cortisol did not mediate this effect. Weight loss mediated the effects on self-esteem but not on depression and body-image. This suggests that lifestyle treatment independent of weight loss can reduce depression and body-image, but both lifestyle treatment and weight loss can improve self-esteem. Thus, a three-component lifestyle intervention based on CBT could prove successful in improving mood in women with PCOS who are overweight or obese and attempting to become pregnant.
Conflict of interest statement
GJ, ADL, AB, RT and JB have no competing interests. JL has received unrestricted research grants from Ferring, MSD, Merck-Serono, Roche Diagnostics and Euroscreen. He received consultancy fees from the following companies: Euroscreen, Danone-Nutricia, Ferring, Roche Diagnostics, and Titus Healthcare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures
Similar articles
-
Weight Reduction Through a Cognitive Behavioral Therapy Lifestyle Intervention in PCOS: The Primary Outcome of a Randomized Controlled Trial.Obesity (Silver Spring). 2020 Nov;28(11):2134-2141. doi: 10.1002/oby.22980. Epub 2020 Sep 23. Obesity (Silver Spring). 2020. PMID: 32969197 Free PMC article. Clinical Trial.
-
A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.Reprod Health. 2017 Mar 6;14(1):34. doi: 10.1186/s12978-017-0295-4. Reprod Health. 2017. PMID: 28264692 Free PMC article. Clinical Trial.
-
Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention.Reprod Biomed Online. 2021 Aug;43(2):298-309. doi: 10.1016/j.rbmo.2021.05.008. Epub 2021 May 19. Reprod Biomed Online. 2021. PMID: 34238659 Clinical Trial.
-
Lifestyle changes in women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2019 Mar 28;3(3):CD007506. doi: 10.1002/14651858.CD007506.pub4. Cochrane Database Syst Rev. 2019. PMID: 30921477 Free PMC article.
-
Implementing the international evidence-based guideline of assessment and management of polycystic ovary syndrome (PCOS): how to achieve weight loss in overweight and obese women with PCOS?J Gynecol Obstet Hum Reprod. 2021 Jun;50(6):101894. doi: 10.1016/j.jogoh.2020.101894. Epub 2020 Aug 16. J Gynecol Obstet Hum Reprod. 2021. PMID: 32814159
Cited by
-
Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial.J Med Internet Res. 2024 Oct 2;26:e55883. doi: 10.2196/55883. J Med Internet Res. 2024. PMID: 39357046 Free PMC article. Clinical Trial.
-
Comprehensive transition of care for polycystic ovary syndrome from adolescence to adulthood.Lancet Child Adolesc Health. 2024 Jun;8(6):443-455. doi: 10.1016/S2352-4642(24)00019-1. Epub 2024 Mar 27. Lancet Child Adolesc Health. 2024. PMID: 38552655 Free PMC article. Review.
-
The Disparity in the Management of Polycystic Ovary Syndrome between Obstetrician-Gynecologists in Different-Level Hospitals under the Hierarchical Medical System.Biomed Res Int. 2022 Sep 15;2022:9778678. doi: 10.1155/2022/9778678. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2024 Jan 9;2024:9809672. doi: 10.1155/2024/9809672. PMID: 36158894 Free PMC article. Retracted.
-
Lifestyle treatment in women with polycystic ovary syndrome: predictors of weight loss and dropout.Brain Behav. 2022 Jul;12(7):e2621. doi: 10.1002/brb3.2621. Epub 2022 Jun 2. Brain Behav. 2022. PMID: 35652323 Free PMC article.
-
Low Doses of Resveratrol Protect Human Granulosa Cells from Induced-Oxidative Stress.Antioxidants (Basel). 2021 Apr 4;10(4):561. doi: 10.3390/antiox10040561. Antioxidants (Basel). 2021. PMID: 33916585 Free PMC article.
References
-
- March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–51. - PubMed
-
- Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–55. - PubMed
-
- Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. - PubMed
-
- Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7. - PubMed
-
- Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical